In various types of cancer, including gastric, breast, malignant mesothelioma, bladder, lung, melanoma, and pancreatic cancers, PD-L1 expression is associated with CSC marker expression, tumor growth, and aggressiveness [124]. Here, CD274 is linked to neoplasm.